Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1689, Issue 1, 2004, Pages 66-74

  Barella, Luca ^a   Muller, Patrick Y ^a   Schlachter, Manfred ^a   Hunziker, Willi ^a   Stöcklin, Elisabeth ^a   Spitzer, Volker ^a   Meier, Nina ^a   De Pascual Teresa, Sonia ^b   Minihane, Anne Marie ^b   Rimbach, Gerald ^c  

^a DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Tocopherol; DNA array; Gene expression; Liver; Rat

Indexed keywords

5ALPHA STEROID REDUCTASE 1; ALPHA TOCOPHEROL; ANDROSTANOLONE; BLOOD CLOTTING FACTOR 9; CD36 ANTIGEN; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; LIVER ENZYME; MESSENGER RNA; SCAVENGER RECEPTOR; STEROID 5ALPHA REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; DNA MICROARRAY; DOWN REGULATION; DRUG EFFECT; DRUG SENSITIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; MALE; MONITORING; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PHARMACOGENETICS; PRIORITY JOURNAL; RANDOMIZATION; RAT; TESTOSTERONE BLOOD LEVEL; UPREGULATION; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; ANIMAL FEED; ANIMALS; ANTIGENS, CD36; BODY WEIGHT; FACTOR IX; GENE EXPRESSION PROFILING; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; LIVER; MALE; PYRUVATE KINASE; RATS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; RNA, MESSENGER; TIME FACTORS;

EID: 2442641218     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.02.002     Document Type: Article

References (52)

1. Brigelius-Flohe R., Traber M.G. Vitamin E: function and metabolism. Faseb Journal. 13:1999;1145-1155
2. Boscoboinik D., Szewczyk A., Hensey C., Azzi A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. Journal of Biological Chemistry. 266:1991;6188-6194
3. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation. 102:2000;82-87
4. Shaw H.M., Huang C. Liver alpha-tocopherol transfer protein and its mRNA are differentially altered by dietary vitamin E deficiency and protein insufficiency in rats. Journal of Nutrition. 128:1998;2348-2354
5. Chojkier M., Houglum K., Lee K.S., Buck M. Long- and short-term D-alpha-tocopherol supplementation inhibits liver collagen alpha1(I) gene expression. American Journal of Physiology. 275:1998;G1480-G1485
6. Ricciarelli R., Maroni P., Ozer N., Zingg J.M., Azzi A. Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radical Biology & Medicine. 27:1999;729-737
7. Aratri E., Spycher S.E., Breyer I., Azzi A. Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Letters. 447:1999;91-94
8. Stocker A., Zimmer S., Spycher S.E., Azzi A. Identification of a novel cytosolic tocopherol-binding protein: structure, specificity, and tissue distribution. IUBMB Life. 48:1999;49-55
9. Elliott R., Ong T.J. Nutritional genomics. British Medical Journal. 324:2002;1438-1442
10. Virgili F., Ambra R., Muratori F., Natella F., Majewicz J., Minihane A.M., Rimbach G. Effect of oxidized low-density lipoprotein on differential gene expression in primary human endothelial cells. Antioxidants & Redox Signalling. 5:2003;237-247
11. van Ommen B., Stierum R. Nutrigenomics: exploiting systems biology in the nutrition and health arena. Current Opinion in Biotechnology. 13:2002;517-521
12. tom Dieck H., Doring F., Roth H.P., Daniel H. Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays. Journal of Nutrition. 133:2003;1004-1010
13. Fischer A., Pallauf J., Gohil K., Weber S.U., Packer L., Rimbach G. Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochemical Biophysical Research Communications. 285:2001;470-475
14. Watanabe C.M., Wolffram S., Ader P., Rimbach G., Packer L., Maguire J.J., Schultz P.G., Gohil K. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proceedings of the National Academy of Sciences of the United States of America. 98:2001;6577-6580
15. Weiser H., Riss G., Kormann A.W. Biodiscrimination of the eight alpha-tocopherol stereoisomers results in preferential accumulation of the four 2R forms in tissues and plasma of rats. Journal of Nutrition. 126:1996;2539-2549
16. Reeves P.G., Nielsen F.H., Fahey G.C. Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. Journal of Nutrition. 123:1993;1939-1951
17. Rettenmaier R., Schuep W. Determination of vitamins A and E in liver tissue. International Journal for Vitamin and Nutrition Research. 62:1992;312-317
18. Vuilleumier J.P., Keller H.E., Gysel D., Hunziker F. Clinical chemical methods for the routine assessment of the vitamin status in human populations. Part I: The fat-soluble vitamins A and E, and beta-carotene. International Journal for Vitamin and Nutrition Research. 53:1983;265-272
19. Sian J., Dexter D.T., Cohen G., Jenner P.G., Marsden C.D. Comparison of HPLC and enzymatic recycling assays for the measurement of oxidized glutathione in rat brain. Journal of Pharmaceutical Pharmacology. 49:1997;332-335
20. Febbraio M., Abumrad N.A., Hajjar D.P., Sharma K., Cheng W., Pearce S.F., Silverstein R.L. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. Journal of Biological Chemistry. 274:1999;19055-19062
21. Aitman T.J., Glazier A.M., Wallace C.A., Cooper L.D., Norsworthy P.J., Wahid F.N., Al-Majali K.M., Trembling P.M., Mann C.J., Shoulders C.C., Graf D., St Lezin E., Kurtz T.W., Kren V., Pravenec M., Ibrahimi A., Abumrad N.A., Stanton L.W., Scott J. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nature Genetics. 21:1999;76-83
22. Miyaoka K., Kuwasako T., Hirano K., Nozaki S., Yamashita S., Matsuzawa Y. CD36 deficiency associated with insulin resistance. Lancet. 357:2001;686-687
23. Blanchard R.K., Moore J.B., Green C.L., Cousins R.J. Modulation of intestinal gene expression by dietary zinc status: effectiveness of cDNA arrays for expression profiling of a single nutrient deficiency. Proceedings of the National Academy of Sciences of the United States of America. 98:2001;13507-13513
24. Lee C.K., Klopp R.G., Weindruch R., Prolla T.A. Gene expression profile of aging and its retardation by caloric restriction. Science. 285:1999;1390-1393
25. Meydani S.N., Meydani M., Blumberg J.B., Leka L.S., Pedrosa M., Diamond R., Schaefer E.J. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. American Journal of Clinical Nutrition. 68:1998;311-318
26. Jager F.C., Houtsmuller U.M. Effect of dietary linoleic acid on vitamin E requirement and fatty acid composition of erythrocyte lipids in rats. Nutrition Metabolism. 12:1970;3-12
27. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacology and Therapeutics. 51:1991;155-194
28. Gokkusu C., Mostafazadeh T. Changes of oxidative stress in various tissues by long-term administration of vitamin E in hypercholesterolemic rats. Clinica Chimica Acta. 328:2003;155-161
29. Voehringer D.W. BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radical Biology & Medicine. 27:1999;945-950
30. Rahman I., MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radical Biology & Medicine. 28:2000;1405-1420
31. van Bladeren P.J. Glutathione conjugation as a bioactivation reaction. Chemical Biological Interactions. 129:2000;61-76
32. Guo Q., Packer L. Ascorbate-dependent recycling of the vitamin E homologue Trolox by dihydrolipoate and glutathione in murine skin homogenates. Free Radical Biology & Medicine. 29:2000;368-374
33. Liebler D.C. The role of metabolism in the antioxidant function of vitamin E. Critical Reviews in Toxicology. 23:1993;147-169
34. Packer L., Weber S.U., Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. Journal of Nutrition. 131:2001;369S-373S
35. Rimbach G., Minihane A.M., Majewicz J., Fischer A., Pallauf J., Virgili F., Weinberg P.D. Regulation of cell signalling by vitamin E. Proceedings of the Nutrition Society. 61:2002;415-425
36. Liu R., Choi J. Age-associated decline in gamma-glutamylcysteine synthetase gene expression in rats. Free Radical Biology & Medicine. 28:2000;566-574
37. Drai J., Bannier E., Chazot C., Hurot J.M., Goedert G., Jean G., Charra B., Laurent G., Baltassat P., Revol A. Oxidants and antioxidants in long-term haemodialysis patients. Farmaco. 56:2001;463-465
38. Devaraj S., Hugou I., Jialal I. Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages. Journal of Lipid Research. 42:2001;521-527
39. Nagy L., Tontonoz P., Alvarez J.G., Chen H., Evans R.M. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 93:1998;229-240
40. Lowe G.D. Factor IX and thrombosis. British Journal of Haematology. 115:2001;507-513
41. Dowd P., Zheng Z.B. On the mechanism of the anticlotting action of vitamin E quinone. Proceedings of the National Academy of Sciences of the United States of America. 92:1995;8171-8175
42. Hirsh J., Warkentin T.E., Shaughnessy S.G., Anand S.S., Halperin J.L., Raschke R., Granger C., Ohman E.M., Dalen J.E. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 119:2001;64S-94S
43. Russell D.W., Wilson J.D. Steroid 5 alpha-reductase: two genes/two enzymes. Annual Review of Biochemistry. 63:1994;25-61
44. Labrie F., Belanger A., Simard J., Luu-The V., Labrie C. "Intracrinology". Autonomy and freedom of peripheral tissues. Annals of Endocrinology (Paris). 56:1995;23-29
45. Stoner E. The clinical effects of a 5 alpha-reductase inhibitor, finasteride, on benign prostatic hyperplasia. The Finasteride Study Group. Journal of Urology. 147:1992;1298-1302
46. Bharaj B., Scorilas A., Giai M., Diamandis E.P. TA repeat polymorphism of the 5alpha-reductase gene and breast cancer. Cancer Epidemiology, Biomarkers & Prevention. 9:2000;387-393
47. Metcalf B.W., Levy M.A., Holt D.A. Inhibitors of steroid 5 alpha-reductase in benign prostatic hyperplasia, male pattern baldness and acne. Trends in Pharmacological Sciences. 10:1989;491-495
48. Berman D.M., Russell D.W. Cell-type-specific expression of rat steroid 5 alpha-reductase isozymes. Proceedings of the National Academy of Sciences of the United States of America. 90:1993;9359-9363
49. Jin Y., Penning T.M. Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Best Practice & Research. Clinical Endocrinology & Metabolism. 15:2001;79-94
50. Preuss H.G., Marcusen C., Regan J., Klimberg I.W., Welebir T.A., Jones W.A. Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH). International Urology and Nephrology. 33:2001;217-225
51. Brigelius-Flohe R., Kelly F.J., Salonen J.T., Neuzil J., Zingg J.M., Azzi A. The European perspective on vitamin E: current knowledge and future research. American Journal of Clinical Nutrition. 76:2002;703-716
52. Hartman T.J., Dorgan J.F., Woodson K., Virtamo J., Tangrea J.A., Heinonen O.P., Taylor P.R., Barrett M.J., Albanes D. Effects of long-term alpha-tocopherol supplementation on serum hormones in older men. Prostate. 46:2001;33-38